| Popis: |
during follow-up at 1 month (P 1⁄4 .545), 3 months (P 1⁄4 .628), and 6months (P1⁄4 .452), the VRTs were comparable in both groups, with no significant differences observed. Clinical success was 100% in both groups at 1 month, with more ofminor complications in the EVLA group (not significant). QOL scores improved significantly in both groups after treatment (P 1⁄4 .001) and were higher (P 1⁄4 .094) in the RFA group at the first follow-up. At 3months and 6months, scores improved further and were almost equal in both groups. Recanalization at 3 months was seen in two of 53 legs (3.8%) in RFA group and in one of 53 legs (1.9%) in the EVLA group (P 1⁄4 1.000). Recanalization at 6 months was four of 49 (8.2%) in RFA and three of 50 (6%) in EVLA (P 1⁄4 .715). All were only segmental recanalizations. Patients with recanalization had lower physiological outcome (lower VRTs) and qualitative outcome (lower SQOR-V scores) compared with patients with a completely occluded GSV. Conclusions: The physiological and qualitative outcomes are significantly better with both EVLA and RFA after treatment in patients with venous insufficiency. The physiological success is comparable after both treatments, with no significant differences at the immediate postoperative period and follow-up visits at 1, 3, and 6 months. The physiological outcome also correlates with the clinical and qualitative outcome as apparent by the lower VRTs and QOL in patients with segmental recanalization of the GSV. Further, there is no significant difference between the two treatments in complication rates, clinical success, and qualitative success at 6 months, except a slightly higher incidence of complications leading to lower QOL in the early postoperative (1-month) period in the EVLA group. |
